Chhatrapati Sambhajinagar: The Government Cancer Hospital (GCH), part of the State Cancer Institute, has received approval to introduce four super-specialty courses aimed at advancing cancer treatment. Starting next year, admissions will be open for 14 seats across these programs, which are expected to help train specialized oncologists and enhance cancer care in the region.
New Super-Specialty Courses
The approved courses and their seat allocation are:
- MCh in Gynaecological Oncology: 4 seats
- DM in Oncopathology: 4 seats
- DM Medical Oncology: 4 seats
- MCh in Head and Neck Surgery: 2 seats
Existing Super-Specialty Courses
The hospital already offers the following programs:
- DM in Paediatric Oncology: 4 seats
- MCh in Surgical Oncology: 3 seats
- DM in Neonatology: 4 seats
Enhanced Services for Patients
The new courses will bolster super-specialty services at GMCH and GCH, benefiting patients across Marathwada and nearby districts.
Dr. Shivaji Sukre, Dean of Government Medical College and Hospital (GMCH), and other senior officials, including Dr. Arvind Gaikwad (OSD, GCH) and Dr. Kailash Sharma (Dean, Tata Memorial Hospital), emphasized the role of these courses in addressing the rising prevalence of cancer and the need for advanced care.
Specialist Training and Research Opportunities
- Medical Oncology: Associate Professor Dr. Anup Toshniwal highlighted that the new DM Medical Oncology course, available after MD Medicine, will increase the number of specialists equipped to handle complex cancer cases and immunotherapy.
- Gynaecological Oncology: Dr. Archana Rathod noted the significance of the MCh Gynaecological Oncology program, offered in only 10 cancer institutes nationwide, which will enhance research and expertise in diagnosing and treating cancers affecting women.
Critical Need for Cancer Specialists
Dr. Kailash Sharma, Academic Dean of Tata Memorial Hospital, stressed the importance of increasing specialists in head, neck, and gynecological cancers. He revealed that 35% of cancer cases involve the head and neck, while gynecological cancers are also on the rise. His efforts over 15 years to increase seats for cancer specialty courses have contributed to this approval.
The new courses mark a significant step forward in producing skilled oncologists and improving cancer treatment outcomes in India.
